Pharmaceutical-Grade Crocus sativus
Structured Botanical Raw Material
SAFFRON PHARMA® is a pharmaceutical-oriented saffron raw material platform designed for extract producers, nutraceutical manufacturers and botanical API processors.
The program is built upon long-term genetic validation and structured analytical development initiated in 1992 within TEHNOFARM S.R.L.
This website represents the global pharmaceutical interface of the saffron program.
Product Focus
Primary Format
Whole Red Stigmas — Sargol Category
- intact, non-powdered material
- controlled low-temperature drying
- moisture standardisation (target 8–10%)
- lot-based traceability
Secondary Format (Conditional)
Pharma-oriented fine powder under controlled processing protocol.
Pharmaceutical Orientation
The objective is not culinary distribution.
The objective is reproducible botanical raw material suitable for:
- extract standardisation
- nutraceutical formulation
- compound profiling
- clinical research supply
Scaling follows analytical confirmation.
Standardisation Model
SAFFRON PHARMA® integrates:
Genetic Stability
Multi-Zone Validation
Controlled Drying Protocol
Analytical Roadmap
Traceable Supply Architecture
The model prioritises parameter stability over peak fluctuation.
European Deployment Pathway
Industrial transition includes Alpine validation and EU-aligned structuring under the TEHNOFARM European framework.
Geographic deployment follows environmental and regulatory logic.
Intended Partners
This platform is structured for:
- pharmaceutical extract manufacturers
- nutraceutical producers
- botanical compound laboratories
- regulated ingredient processors
Retail spice trade and commodity export are not within scope.